Analysis of Gene Expression profiles associated with glioma progression

Molecular Medicine Reports

Volumn 12, Issue 2, 2015, Pages 1884-1890

  Hu, Guozhang ^a   Wei, Bo ^a   Wang, Lina ^b   Wang, Le ^c   Kong, Daliang ^a   Jin, Ying ^d   Sun, Zhigang ^a,e,f  

^a Department of Emergency Medicine ^*  (China)

^b JILIN UNIVERSITY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d Jilin Oil Field General Hospital   (China)

^e University for Nationalities   (China)

^f CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Differentially expressed genes; Gene expression profile; Glioma progression; Kyoto encyclopedia of genes and genomes enrichment pathway

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 A2; COLLAGEN TYPE 3; COLLAGEN TYPE 3 A1; COLLAGEN TYPE 4; COLLAGEN TYPE 4 A1; COLLAGEN TYPE 6; COLLAGEN TYPE 6 A2; HLA ANTIGEN CLASS 2; HLA DA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; HLA G ANTIGEN; UNCLASSIFIED DRUG; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRANSCRIPTOME; TUMOR MARKER;

ARTICLE; ASTROCYTOMA; CANCER DIAGNOSIS; CHOLERA; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIFFERENTIALLY EXPRESSED GENE; DOWN REGULATION; EPILEPSY; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC SCREENING; GLIOBLASTOMA; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INTRACELLULAR SIGNALING; MICROARRAY ANALYSIS; PHAGOSOME; PROTEIN PROTEIN INTERACTION; SHORT TIME SERIES EXPRESSION MINER; SIGNIFICANCE ANALYSIS OF MICROARRAY; TUMOR GROWTH; UPREGULATION; BRAIN TUMOR; DISEASE COURSE; DNA MICROARRAY; GENETIC DATABASE; GENETICS; GLIOMA; METABOLISM; PATHOLOGY;

BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CLUSTER ANALYSIS; DATABASES, GENETIC; DISEASE PROGRESSION; GLIOMA; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN INTERACTION MAPS; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSCRIPTOME;

EID: 84994745016     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3583     Document Type: Article

References (31)

1. Mamelak AN and Jacoby DB: Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4:175-186, 2007.
2. Goebell E, Paustenbach S, Vaeterlein O, et al: Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging. Radiology 239:217-222, 2006.
3. Fine HA, Dear KB, Loeffler JS, Black PM and Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71:2585-2597, 1993.
4. Stark AM, Hugo H, Witzel P, Mihajlovic Z and Mehdorn HM: Age-related expression of p53, Mdm2, EGFR and Msh2 in glioblastoma multiforme. Zentralbl Neurochir 64:30-36, 2003.
5. Li J, Yen C, Liaw D, et al: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275:1943-1947, 1997.
6. Simon M, Köster G, Menon AG and Schramm J: Functional evidence for a role of combined CDKN2A (p16-p14ARF)/CDKN2B (p15) gene inactivation in malignant gliomas. Acta Neuropathol 98:444-452, 1999.
7. Freije WA, Castro-Vargas FE, Fang Z, et al: Gene expression profiling of gliomas strongly predicts survival. Cancer Res 64:6503-6510, 2004.
8. Shai R, Shi T, Kremen TJ, et al: Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22:4918-4923, 2003.
9. Nutt CL, Mani D, Betensky RA, et al: Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63:1602-1607, 2003.
10. Sun L, Hui AM, Su Q, et al: Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9:287-300, 2006.
11. Gruber HE, Ingram JA, Hoelscher GL, Zinchenko N, Hanley EN Jr and Sun Y: Asporin, a susceptibility gene in osteoarthritis, is expressed at higher levels in the more degenerate human intervertebral disc. Arthritis Res Ther 11:R47, 2009.
12. Larsson O, Wahlestedt C and Timmons JA: Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinformatics 6:129, 2005.
13. Ernst J and Bar-Joseph Z: STEM: a tool for the analysis of short time series gene expression data. BMC Bioinformatics 7:191, 2006.
14. Glaab E, Baudot A, Krasnogor N, Schneider R and Valencia A: EnrichNet: network-based gene set enrichment analysis. Bioinformatics 28:i451-i457, 2012.
15. Szklarczyk D, Franceschini A, Kuhn M, et al: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39(Database Issue):561-568, 2011.
16. Paulus W and Tonn JC: Interactions of glioma cells and extracellular matrix. J Neurooncol 24:87-91, 1995.
17. Payne LS and Huang PH: The pathobiology of collagens in glioma. Mol Cancer Res 11:1129-1140, 2013.
18. Bajjalieh SM, Peterson K, Shinghal R and Scheller RH: SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 257:1271-1273, 1992.
19. Dong M, Yeh F, Tepp WH, et al: SV2 is the protein receptor for botulinum neurotoxin A. Science 312:592-596, 2006.
20. Crèvecoeur J, Foerch P, Doupagne M, et al: Expression of SV2 isoforms during rodent brain development. BMC Neurosci 14:87, 2013.
21. de Groot M, Aronica E, Heimans JJ and Reijneveld JC: Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma. Neurology 77:532-539, 2011.
22. La Torre D, Maugeri R, Angileri FF, et al: Human leukocyte antigen frequency in human high-grade gliomas: a case-control study in Sicily. Neurosurgery 64:1082-1088, 2009.
23. ∗14. J Neurooncol 77:213-217, 2006.
24. Wiendl H, Mitsdoerffer M, Hofmeister V, et al: A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 168:4772-4780, 2002.
25. Hsieh D, Hsieh A, Stea B and Ellsworth R: IGFBP2 promotes glioma tumor stem cell expansion and survival. Biochem Biophys Res Commun 397:367-372, 2010.
26. Otani K, Ujike H, Tanaka Y, et al: The GABA type A receptor a5 subunit gene is associated with bipolar I disorder. Neurosci Lett 381:108-113, 2005.
27. Belelli D, Harrison NL, Maguire J, Macdonald RL, Walker MC and Cope DW: Extrasynaptic GABAA receptors: form, pharmacology and function. J Neurosci 29:12757-12763, 2009.
28. Smits A, Jin Z, Elsir T, et al: GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome. PLoS One 7:e37041, 2012.
29. Bliss TV and Collingridge GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39, 1993.
30. Dong H, Siu H, Luo L, Fang X, Jin L and Xiong M: Investigation gene and microRNA expression in glioblastoma. BMC Genomics 11(Suppl 3):16, 2010.
31. Lu YM, Jia Z, Janus C, et al: Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 17:5196-5205, 1997.